Table 1.
Subregion | Parkinson’s Group | Control Group | ||||
---|---|---|---|---|---|---|
Mean Kocc (min−1) | SD (min−1) | Annual decline (min−1) | Mean Kocc (min−1) | SD (min−1) | Annual decline (min−1) | |
CL Caudate. | .0100 | .0015 | .0005 | .0117 | .0011 | .0001 |
CL Putamen | .0072 | .0015 | .0005 | .0137 | .0014 | .0001 |
CL Post. Putamen | .0052 | .0016 | .0004 | .0135 | .0010 | .0002 |
IL Caudate | .0106 | .0017 | .0006 | .0122 | .0015 | .0002 |
IL Putamen | .0083 | .0023 | .0006 | .0136 | .0011 | .0001 |
IL Post. Putamen | .0065 | .0022 | .0006 | .0131 | .0018 | .0001 |
Baseline means, standard deviations, and linear regression decline rate estimatesfor Kocc values derived from striatal subregions: CL, contralateral to initially symptomatic limbs; IL, ipsilateral to initially symptomatic limbs; Kocc, uptake rate constant for FDOPA; Post., posterior; SD, Standard deviation.